Full Length Research Paper
References
Adouani B, Alami R, Laouina A, Benahadi A, Boulahdid S, Mokhtari A, Soulaymani A, Abouyoub A, Benajiba M (2013). Hepatitis B in Moroccan blood donors?: A decade trend of the HBsAg prevalence in a resources limited country: Hepatitis B in Moroccan blood donors. Transfusion Medicine 23(6):432 437. |
|
Atipo-Ibara BI, Itoua-Ngaporo AN, Dzia-Lepfoundzou A, Ahoui-Apendi C, Deby-Gassaye C, Bossali F, Ngami Rody S, Ennajï M, Boumba A, Ibara JR. (2015). Virus de l'hépatite B au Congo (Brazzaville)?: Séroprévalence et diversité génétique chez les donneurs de sang en zones hyper endémiques. Journal Africain d'Hépato-Gastroentérologie 9(3):127 131. |
|
Bivigou-Mboumba B, François-Souquière S, Deleplancque L, Sica J, Mouinga-Ondémé A, Amougou-Atsama M, Chaix ML, Njouom R, Rouet F (2016). Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon. PLOS ONE 11(1):e0143869. |
|
Choga WT, Anderson M, Zumbika E, Moyo S, Mbangiwa T, Phinius BB, Melamu P, Kayembe MK, Kasvosve I, Sebunya TK, Blackard JT, Essex M, Musonda RM, Gaseitsiwe S (2019). Molecular characterization of hepatitis B virus in blood donors in Botswana. Virus Genes 55(1):33 42. |
|
Dodd RY, Notari EP, Nelson D, Foster GA, Krysztof DE, Kaidarova Z, Milan-Benson L, Kessler DA, Shaz BH, Vahidnia F, Custer B, Stramer SL, for the NHLBI Retrovirus Epidemiology Donor Study (REDS)-II (2016). Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States. Transfusion 56(11):2781 2789. |
|
Eke CB, Ogbodo SO, Ukoha OM, Ibekwe RC, Asinobi IN, Ikuna AN, Ibe BC (2015). Seroprevalence and Risk Factors of Hepatitis B Virus Infection among Adolescents in Enugu, Nigeria. Journal of Tropical Pediatrics, fmv035. |
|
Eko Mba JM, Bisseye C, Ntsame Ndong JM, Mombo LE, Bengone C, Mouelet Migolet G, M'batchi B, Kosiorek HE, Butterfield RJ, Roberts LR, Borad MJ, Nagalo BM (2018). Prevalent hepatitis B surface antigen among first-time blood donors in Gabon. PLoS ONE 13(4):e0194285. |
|
Farshadpour F, Taherkhani R, Tajbakhsh S, Gholizadeh Tangestani M, Hajiani G, Sharifi N, Taherkhani S, Nejadbolkheyr A (2016). Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran?: An Eleven-Year Retrospective Study. PLoS ONE 11(6):e0157615. |
|
Groc S, Abbate JL, Le Gal F, Gerber A, Tuaillon E, Albert JL, Nkoghé D, Leroy EM, Roche B, Becquart P (2019). High prevalence and diversity of hepatitis B and hepatitis delta virus in Gabon. Journal of Viral Hepatitis 26(1):170 182. |
|
Hoffmann CJ, Dayal D, Cheyip M, McIntyre JA, Gray GE, Conway S, Martinson NA (2012). Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa. International Journal of STD and AIDS 23(10):e10 e13. |
|
Jagannathan L, Chaturvedi M, Mudaliar S, Kamaladoss T, Rice M, Murphy EL (2010). Risk factors for chronic hepatitis B virus infection among blood donors in Bangalore, India. Transfusion Medicine 20(6):414 420. |
|
Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I (2010). The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion 50(2):433 442. |
|
Kounegnigan Rerambiah L, Essola Rerambiah L (2014). The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. Blood Transfusion. |
|
Makuwa M, Mintsa-Ndong A, Souquiere S, Nkoghe D, Leroy EM, Kazanji M (2009). Prevalence and Molecular Diversity of Hepatitis B Virus and Hepatitis Delta Virus in Urban and Rural Populations in Northern Gabon in Central Africa. Journal of Clinical Microbiology, 47(7):2265 2268. |
|
Matthews PC, Geretti AM, Goulder PJR, Klenerman P (2014). Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa. Journal of Clinical Virology 61(1):20 33. |
|
Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson JM, Warszawski J, Steinmetz J, Coste D, Meyer JF, Leiser S, Giordanella JP, Gueguen R, Desenclos JC (2010). Prevalence of hepatitis B and hepatitis C virus infections in France in 2004?: Social factors are important predictors after adjusting for known risk factors: Prevalence of Hepatitis B and C in France. Journal of Medical Virology 82(4):546 555. |
|
Ragheb M, Elkady A, Tanaka Y, Murakami S, Attia FM, Hassan AA, Hassan MF, Shedid MM, Abdel Reheem HB, Khan A, Mizokami M (2012). Multiple intra-familial transmission patterns of hepatitis B virus genotype D in north-eastern Egypt. Journal of Medical Virology 84(4):587 595. |
|
Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunert HP, Prince A (2010). Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sanguinis 98(3p2):403 414. |
|
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ (2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection?: A systematic review of data published between 1965 and 2013. The Lancet 386(10003):1546 1555. |
|
Song Y, Bian Y, Petzold M, Ung COL (2014). Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western China, 2005 through 2010. PLoS ONE 9(4):e94528. |
|
Tagny CT, Owusu-Ofori S, Mbanya D, Deneys V (2010). The blood donor in sub-Saharan Africa?: A review. Transfusion Medicine20(1):1 10. |
|
Te HS, Jensen DM (2010). Epidemiology of Hepatitis B and C Viruses?: A Global Overview. Clinics in Liver Disease 14(1):1 21. |
|
Twagirumugabe T, Swaibu G, Walker TD, Lindh M, Gahutu JB, Bergström T, Norder H (2017). Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1. BMC Infectious Diseases 17(1):32. |
|
Wasfi OAS, Sadek NA (2011). Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt. EMHJ - Eastern Mediterranean Health Journal 17(3):238-242, 2011 |
|
World Health Organization (WHO) (2016). Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. World Health Organization. |
|
World Health Organization (WHO) (2008). Universal access to safe blood transfusion. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0